IDH1 and neoplasm: Interestingly, this paradox has been brought into even sharper focus by the striking mutational profiles that do exist in very specific 'metabolic’ tumor suppressor genes (that is, FH and SDH) that are inactivated in specific rare cancer syndromes [30-32], and in the IDH1 and 2 oncogenes.